Cessatech A/S Logo

Cessatech A/S

CESSA | SPGR

Overview

Corporate Details

ISIN(s):
DK0061411964
LEI:
549300WO5SKVXWPOXR16
Country:
Denmark
Address:
Kanonbådsvej 2, 1437 København K
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cessatech A/S is a clinical-stage pharmaceutical company specializing in the research and development of pain relief treatments for children. A spinout from Copenhagen University Hospital, Rigshospitalet, the company focuses on addressing unmet medical needs in pediatric care. Its lead asset, CT001, is a non-invasive analgesic nasal spray designed for children aged 1-17 experiencing acute pain or pain related to medical procedures. Cessatech's business model involves identifying and developing drugs with proven efficacy in adults for pediatric applications, aiming for a potentially shorter and de-risked development pathway. The company is managed by a team with extensive experience in drug development, pediatric research, and product launches.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Cessatech A/S. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cessatech A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cessatech A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Enlivex Therapeutics Ltd. Logo
Developing a cell therapy platform to treat inflammatory diseases by reprogramming macrophages.
Israel ENLV
E-Novia Logo
A deep-tech factory building Physical AI ventures for mobility, logistics, and automation.
Italy E9IA
ERYTECH Pharma S.A. Logo
Biopharma firm developing phage therapies to fight antimicrobial resistance (AMR).
France ERYP
EUROESPES Logo
Research & patient care for CNS diseases via personalized genomic medicine.
Spain EEP
Eurofins-Cerep Logo
CRO offering preclinical drug profiling, screening & pharmacology testing for pharma/biotech.
France ALECR
Evogene Ltd. Logo
An AI-powered computational biology platform for life-science products in health and agriculture.
Israel EVGN
Evotec SE Logo
A drug discovery and development partner for pharma, biotech, and academia.
Germany EVT
EXACT Therapeutics AS Logo
Biopharma developing ultrasound technology for targeted drug delivery in oncology.
Norway EXTX
ExpreS2ion Biotech Holding AB Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using a protein platform.
Sweden EXPRS2
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN